Core Viewpoint - The company Jinhe Biological (002688) plans to issue A-shares to specific investors through a simplified procedure, aiming to raise funds for wastewater treatment expansion and other projects, with a total fundraising target not exceeding 300 million yuan [1][2]. Fundraising Details - The issuance will target no more than 35 specific institutional investors, including securities investment fund management companies, securities companies, trust companies, and qualified foreign institutional investors [1]. - The total amount to be raised is capped at 30 million yuan, which will be used for wastewater treatment expansion, new product warehouse construction, and to supplement working capital [2][3]. Project Allocation - The funds will be allocated as follows: - Wastewater treatment expansion and water resource recycling project: 135.52 million yuan - New product warehouse construction (grain storage): 128.01 million yuan - Supplementing working capital: 36.47 million yuan - Total: 300 million yuan [3]. Shareholding Structure - As of the announcement date, the company has a total share capital of 771,634,398 shares, with the actual controllers holding 33.20% of the shares. The issuance is not expected to change the control of the company [4]. Previous Fundraising - In a previous fundraising round, the company issued 145,132,743 shares at a price of 5.65 yuan per share, raising approximately 820 million yuan, which has been fully utilized for its intended purposes [5]. Recent Shareholder Activity - The controlling shareholder, Inner Mongolia Jinhe Holdings, completed a share reduction plan, selling 22,563,100 shares, which accounted for 3% of the total share capital, primarily to repay pledged debts [6]. Financial Performance - For the first half of 2025, the company reported a revenue of 1.39 billion yuan, a year-on-year increase of 30.45%, and a net profit attributable to shareholders of 138 million yuan, up 51.52% [7][8].

本次发行预计募集资金总额不超过3亿元(含本数)，扣除发行费用后将全部用于污水处理扩容及水资源 再生利用提标扩建工程项目、新建产品库房建设项目(粮食储备库)、补充流动资金。 金河生物（002688）(002688.SZ)披露2025年度以简易程序向特定对象发行A股股票预案，公司拟向不超 过35名(含)特定对象发行股票，发行价格不低于定价基准日前二十个交易日公司股票均价的80%。本次 发行的股票数量按照募集资金总额除以发行价格确定，且不超过本次发行前公司总股本的30%。 ...